Test Price
2,800 AED✅ Home Collection Available
ASAH1 Gene Sequencing for Spinal Muscular Atrophy with Progressive Myoclonic Epilepsy (SMA-PME) in UAE | 2,800 AED | 2026 DHA Guidelines
تحليل جين ASAH1 للكشف عن ضمور العضلات الشوكي مع الصرع الرمعي التدريجي (SMA-PME) في الإمارات | 2,800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary – UAE Market
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity achieved through ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) accredited NGS processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain transport and VIP Mobile Phlebotomy (8 AM – 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance for expert result interpretation, led by DHA-licensed specialists.
- Insurance: Direct Billing Verification & Pre-approval Support via WhatsApp at +971 54 548 8731.
يقدم هذا الاختبار دقة تشخيصية تبلغ 99.9% ويتم إجراؤه تحت إرشادات هيئة الصحة بدبي لعام 2026.
Clinical Overview & Patient Journey
The ASAH1 gene sequencing test is a next-generation sequencing (NGS) assay that detects pathogenic variants linked to spinal muscular atrophy with progressive myoclonic epilepsy (SMA-PME), a rare neurogenetic disorder. يكشف تحليل جين ASAH1 عن الطفرات المسببة للمرض، مما يتيح تشخيصًا دقيقًا وتخطيطًا علاجيًا فرديًا. This single-gene analysis offers a focused, cost-effective alternative to broad panel or exome sequencing for patients with hallmark symptoms.
| Feature | Our ASAH1 NGS Test | Closest Alternative (Research-Grade Exome) |
|---|---|---|
| Diagnostic Precision | 99.9% sensitivity & specificity for ASAH1 variants | Variable; incidental findings common |
| Methodology | NGS, full gene sequencing with CNV analysis | Whole exome sequencing (WES) without focused ASAH1 coverage |
| Turnaround Time | 3–4 weeks | 8–12 weeks or longer |
| Price (AED) | 2,800 | 5,000–8,000 (research only) |
| Regulatory Clearance | DHA/MOHAP-compliant, ISO 9001:2015 | Often not clinically accredited |
Physician Insight & Safety Protocol
“This test confirms the molecular diagnosis of SMA-PME, but clinical correlation remains paramount. Seizure semiology, EMG findings, and neurological examination must be integrated with genetic results. I strongly advise genetic counseling before and after testing.”
— Dr. Prabhakar Reddy, DHA License 61713011
Medication Warning:
Do not discontinue prescribed antiepileptic or myorelaxant medication without consulting your physician. Abrupt changes may trigger status epilepticus or respiratory compromise.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Active, untreated seizure clusters requiring emergency intervention; severe cardiorespiratory instability; inability to provide informed consent (for minors, legal guardian consent mandated per UAE CDS Law 2026).
- ER Red Flags: Sudden increase in seizure frequency with loss of consciousness lasting >5 minutes, respiratory distress, aspiration, or status epilepticus – seek immediate emergency care.
- Home Collection Restriction: Patients with ongoing febrile illness or acute neurological exacerbation should defer home phlebotomy until clinically stable.
Patient FAQ & Clinical Guidance
1. What exactly does the ASAH1 gene test diagnose, and how accurate is it?
This NGS-based test detects pathogenic mutations in the ASAH1 gene, confirming spinal muscular atrophy with progressive myoclonic epilepsy (SMA-PME) with 99.9% diagnostic sensitivity. It differentiates SMA-PME from other causes of myoclonus or motor regression, providing a definitive genetic diagnosis when clinical criteria are met. Results are interpreted following ACMG guidelines to ensure clinical relevance.
2. What sample is required, and how is the home collection performed?
A standard venipuncture (whole blood in EDTA tube), a dried blood spot on an FTA card, or previously extracted DNA is accepted. Our DHA-licensed phlebotomists arrive at your home between 8 AM and 11 PM with an ISO-certified cold chain kit, ensuring sample stability from collection to laboratory. For infants or children, a simple heel-prick or FTA card method is used, requiring only a few drops of blood.
3. هل يتطلب اختبار جين ASAH1 استشارة وراثية؟ وماذا تعني النتيجة السلبية؟
اختبار جين ASAH1 يتطلب جلسة استشارة وراثية إلزامية لرسم شجرة العائلة وتفسير النتائج بدقة. النتيجة السلبية قد تستبعد الطفرات النقطية الشائعة ولكن لا تستبعد جميع التغيرات الجينية النادرة أو الحذف الجيني العميق، لذا يلزم التقييم السريري المستمر. نحرص على تقديم شرح مفصل بعد الفحص عبر استشاري الوراثة الطبية.
UAE Regulatory Compliance
This adheres to Federal Decree-Law No. 41 of 2024 (Art. 87) on medical liability, the UAE Child Data Safeguarding Law 2026 for minors, and the UAE Personal Data Protection Law (PDPL). Facility License: 9834453. Laboratory processes are ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139).
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians